Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.59 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | MAOB | P27338 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3628980 | 0.90 | ESR1 (0.61) | PPARGTDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL9329226 | 0.88 | MAOB (0.68) | PPARGTDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL5085480 | 0.87 | PPARG (0.71) | PPARGTDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL6394260 | 0.85 | ESR1 (0.56) | PPARGTDP1KMT2ASLC6A2ALDH1A1 | |
| SCHEMBL28956479 | 0.84 | PPARG (0.56) | PPARGTDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL9190522 | 0.83 | MAOB (0.51) | KMT2AALDH1A1MAPTMAOBKDM4E | |
| SCHEMBL14937718 | 0.83 | TDP1 (0.65) | TDP1KMT2AALDH1A1MAPTKDM4E | |
| SCHEMBL9329029 | 0.83 | MAOB (0.47) | PPARGTDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL16673146 | 0.83 | LMNA (0.59) | PPARGTDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL9578209 | 0.82 | L3MBTL1 (0.58) | TDP1KMT2AALDH1A1MAPTMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119584860-A | Comprising biodegradable microcapsule composition | 奇华顿股份有限公司 | 2025-03-07 | — | — | CN | disclosed |
| US-20240374492-A1 | A SUNSCREEN COMPOSITION COMPRISING AVOBENZONE AND A METHOD FOR PHOTOSTABILIZATION | ISP INVESTMENTS LLC (US) | 2024-11-14 | — | — | US | disclosed |
| CN-118771982-A | Method for improving yield of aldol resin in process of producing methylbenzoic acid based on dimethylbenzene oxidation | 阿拉善左旗旻利化工有限责任公司 | 2024-10-15 | — | — | CN | disclosed |
| US-20240016775-A1 | ANTI-CORONAVIRUS APPLICATION OF POLY ADP RIBOSE POLYMERASE INHIBITOR | FUKANG (SHANGHAI) HEALTH TECHNOLOGY CO., LTD (CN) | 2024-01-18 | — | — | US | disclosed |
| US-20240016775-A1 | ANTI-CORONAVIRUS APPLICATION OF POLY ADP RIBOSE POLYMERASE INHIBITOR | FUKANG (SHANGHAI) HEALTH TECHNOLOGY CO., LTD (CN) | 2024-01-18 | — | — | US | disclosed |
| US-20230015617-A1 | PHTHALAZINONE DERIVATIVES | KUDOS PHARMACEUTICALS LIMITED (GB) | 2023-01-19 | — | — | US | disclosed |
| US-11160803-B2 | Phthalazinone derivatives | KUDOS PHARMACEUTICALS LIMITED (GB) | 2021-11-02 | — | — | US | disclosed |
| EP-3883647-A1 | C10-ALKYLENE SUBSTITUTED 13-MEMBERED MACROLIDES AND USES THEREOF | Zikani Therapeutics, Inc. (US) | 2021-09-29 | — | — | EP | disclosed |
| CN-106458827-B | Process for purifying benzoic acid | 苏尔寿管理有限公司 | 2021-07-09 | — | — | CN | disclosed |
| CN-110845327-A | Process for purifying benzoic acid | 苏舍化学技术有限公司 | 2020-02-28 | — | — | CN | disclosed |
| EP-2390245-A1 | Enantiomerically pure amines | Nabriva Therapeutics AG (AT) | 2011-11-30 | — | — | EP | disclosed |
| US-8022072-B2 | Azolylmethylidenehydrazine derivative and use thereof | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 2011-09-20 | — | — | US | disclosed |
| US-7993732-B2 | Heat-sensitive pressure-sensitive adhesive and heat-sensitive adhesive material | RICOH COMPANY, LTD. (JP) | 2011-08-09 | — | — | US | disclosed |
| US-7795261-B2 | Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists | JANSSEN PHARMACEUTICA NV (BE) | 2010-09-14 | — | — | US | disclosed |
| US-20100190754-A1 | AZOLYLMETHYLIDENEHYDRAZINE DERIVATIVE AND USE THEREOF | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 2010-07-29 | — | — | US | disclosed |
| US-7572786-B2 | Irritable bowel syndrome; tachykinin mediated condition such as schizophrenia, emesis, anxiety, depression, irritable bowel syndrome, circadian rhythm disturbances, pain, neurogenic inflammation, asthma, micturition disorder or nociception | JANSSEN PHARMACEUTICA, N.V. (BE) | 2009-08-11 | — | — | US | disclosed |
| US-20080026205-A1 | Heat-sensitive pressure-sensitive adhesive and heat-sensitive adhesive material | RICOH COMPANY, LTD. (JP) | 2008-01-31 | — | — | US | disclosed |
| EP-1882726-A1 | Heat-sensitive pressure-sensitive adhesive and heat-sensitive adhesive material | Ricoh Company, Ltd. (JP) | 2008-01-30 | — | — | EP | disclosed |
| WO-2004080976-A1 | PHTHALAZINONE DERIVATIVES | KUDOS PHARMACEUTICALS LIMITED (GB) | 2004-09-23 | — | — | WO | disclosed |
| US-4387243-A | Continuous production of ortho-phthalic acid product by two-step catalytic neat oxidation of liquid ortho-xylene with air | STANDARD OIL COMPANY (INDIANA) (US) | 1983-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11160803-B2 | Phthalazinone derivatives | NR0B1, NR0B2, NR2E1 | PPARG 523/4885TDP1 3363/4885KMT2A 2203/4885 |
| US-20240016775-A1 | ANTI-CORONAVIRUS APPLICATION OF POLY ADP RIBOSE POLYMERASE INHIBITOR | PARP3, PARP1, PARP4 | PPARG 4280/4885TDP1 288/4885KMT2A 2392/4885 |
| US-20230015617-A1 | PHTHALAZINONE DERIVATIVES | NR0B1, NR0B2, NR2E1 | PPARG 481/4885TDP1 3392/4885KMT2A 2142/4885 |
| US-20100190754-A1 | AZOLYLMETHYLIDENEHYDRAZINE DERIVATIVE AND USE THEREOF | ARSA, AHR, HRH2 | PPARG 1727/4885TDP1 4865/4885KMT2A 1190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.